Mednet TV
Lung Academy webinar: Focus on difficult to treat patients with advanced NSCLC
In this webinar our experts will focus on the difficult to treat patients with advanced NSCLC, with a particular focus on patients with a squamous histology and locally advanced disease (Stage III) patients.
Mednet TV
Webinar: Challenges in early-stage cutaneous T-cell lymphoma – diagnosis and management
Join us in this expert meeting where our experts will focus on the challenges in early-stage cutaneous T-cell lymphoma. Please register now.
Mednet TV
This webcast was broadcasted live on Thursday the 27th of August 2020. You can see it here on demand.
Topics:
Target audience: This webcast is primarily intended for dermatologists. Other interested healthc care professionales are welcome to join.
Mednet TV
Join the experts to discuss about how sac dynamics can influence EVAR outcomes and to learn how to optimize sac regression in straightforward and hostile anatomies.
Target audience: This webcast is primarily intended for cardiologists, specialists in internal medicine and vascular surgeons. Other interested healthc care professionales are welcome to join.
Mednet TV
This broadcast was shown live on Tuesday, October 29th 2019. You can see it here on demand.
During this online webinar experts on Cardiology from all over Europe discussed the following topics:
Target audience
This webcast is primarily intended for cardiologists. In addition, this webcast is also interesting for all HCP being interested in cardiology.
Mednet TV
Agenda
- Hyperuricaemia as a cardiovascular risk factor – Prof. C. Borghi
- Serum uric acid and renal disease & CKD patient case – Prof. J. Kielstein
- Importance of adherence in gout treatment and why to treat below 6mg/dl? – Prof. F. Perez Ruiz
- Questions & Answers
Target audience: This web-tv is for all HCPs interested in hyperuricaemia.
Mednet TV
This broadcast was shown live on Monday, June 11th 2018. You can see it here on demand.
During this online web-tv experts on Cardiology from all over Europe will discuss new ESC/ESH guidelines on management of hypertension.
Target audience: This web-tv is for all HCP being interested in cardiology.
Mednet TV
This broadcast was shown live on Thursday, 14 December 2017. You can see it here on demand (press 'Read more').
The topics discussed during this MTC web-tv are the following:
• When should physicians initiate treatment? Dr. David Viola (Pisa, Italy)
• Which TKI to select? Prof. Enrique Grande (Madrid, Spain)
• Patient education prior to treatment and effective strategies for side effect minimization. Prof. Thera Links (Groningen, The Netherlands)
Moderator: Dr. Ayan Panja, NHS GP Partner in St Albans, clinical adviser to NHS Choices and the resident doctor for BBC World News.
Target Audience: This web-tv is for physicians with an interest in MTC, in particular Endocrinologists, Oncologists, Nuclear Medicine Specialists and Surgeons.
Mednet TV
This broadcast was shown live on Wednesdays, 13 December 2017. You can see it here on demand (press 'Read more').
Topics discussed during this DTC web-tv are the following:
• Current Trends in ablative treatment. Dr. Slimane Zerdoud (Toulouse, France)
• Why ablate? Prof. Frederik Verburg (Marburg, Germany)
• How to ablate? Dr. David Viola (Pisa, Italy)
Moderator: Dr. Ayan Panja, NHS GP Partner in St Albans, clinical adviser to NHS Choices and the resident doctor for BBC World News.
Target Audience: This web-tv is for physicians with an interest in DTC, in particular Endocrinologists, Nuclear Medicine Specialists and Surgeons.
Mednet TV
Russian translation is provided. Click here for the Russian version
This broadcast was shown live on Wednesday, December 13th 2017. You can see it here on demand.
During this online web-tv experts on Cardiology from all over Europe share their knowledge and experience on topics like hypertension, heart failure, stable angina and hyperuricaemia. They not only talk about challenges but also offer solutions. By discussing cases they are able to give practical recommendations.
Target Audience: Cardiologists and other HCP being interested in cardiology.
